News

Cascade funding opportunity: cybersecurity for the transport sector

Published on
| 3 months ago
Programmes
  • Civil Security
  • Climate, Energy, Mobility
  • Cybersecurity

TRUNSPORT, an initiative funded under the Digital Europe programme, has opened a call for Financial Support to Third Parties (FSTP) grants. With this call, TRUNSPORT will provide financial support and engage into its cybersecurity ecosystem transport sector entities (road, rail, air, and water). In a second open call, that will open later, it will expand participation to entities operating in other OT/IT-based critical infrastructure sectors.

The project aims to award funding to 21 projects for transport sector entities to strengthen cybersecurity resilience through the TRUNSPORT Cyber Support Hub, within a structured 9-month programme of mentoring, training, and hands-on access to cybersecurity services.

The TRUNSPORT Open Call 1 provides lump-sum grants of up to EUR 60,000.

More information on the call can be found on the TRUNSPORT website and the dedicated page on the Funding & Tenders Portal.

Deadline to submit applications is 30 October 2026.

Background:

TRUNSPORT is dedicated to strengthening cybersecurity resilience across the transport sector and related critical infrastructures. As digitalisation accelerates, transport systems face growing cyber threats that can disrupt operations and compromise safety. TRUNSPORT addresses these challenges through its Cyber Security Hub (CSH), a one-stop platform offering advanced services for preparedness, protection, and mutual assistance.

 

Related news

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Latest news

2055 articles available Browse all news
  • Health

One Health AMR Partnership: Call 2027 opening soon

The European Partnership on One Health Antimicrobial Resistance (OH AMR) is about to launch the joint transnational call 2027 (JTC2027) “Understand, Model and Stop AMR Transmission”. The call opens on 18 November 2026. The call will follow a two-step evaluation process.Novel and improved measures are urgently required...

Read more
  • Enhancing EU R&I

ERA in Practice: A guide for the research and innovation community

The European Commission Directorate-General for Research & Innovation has published European Research Area (ERA) in Practice: A Guide for the R&I Community, developed with the support of INSPIRING ERA. The publication connects the four European Research Area policy priorities for joint action of the Pact for Research and Innovation...

Read more
  • Culture and society

SSH Opportunities document for the 2027 Horizon Europe calls updated

Net4Society, the NCP network for Cluster 2, has published an updated edition of the document "Opportunities for Researchers from the Social Sciences and Humanities (SSH) in Horizon Europe". This document is designed to help potential applicants to find SSH-related call topics across the different parts of Horizon Europe in Work Programmes...

Read more
  • Agro-Food, Environment

Topic update - HORIZON-CL6-2027-02-FARM2FORK-05

On 5 November 2026, the European Commission published a correction for Horizon Europe topic HORIZON-CL6-2027-02-FARM2FORK-05. Under the section ‘Topic description - Scope’, the sentence on collaboration with projects funded under other topics in the work programme has been updated. The original text referred to...

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.